Application of triptolide on in vitro HMEC-1 (human dermal microvascular endothelial cells) angiogenesis model resulted in miR-92a-mediated downregulation of the eNOS, VEGFR2 and VEGF expression, thus, could potentially suppress atherosclerosis [91]. The gene discussed is VEGFA; the disease is atherosclerosis.